Bill C-64, An Act respecting pharmacare (Pharmacare Act)

The "Bill C-64, An Act Respecting Pharmacare (Pharmacare Act)" was introduced by the Government of Canada on February 29, 2024 to establish the foundational principles for national universal pharmacare. Implemented at the national level and led by the Minister of Health, this proposed legislation targets all Canadians, aiming to ensure universal, single-payer, first-dollar coverage for key medications, initially focusing on contraception and diabetes medications. Key measures include a commitment to collaborate with provinces and territories to provide comprehensive coverage and the establishment of a fund supporting access to diabetic devices and supplies. The Act mandates the Canadian Drug Agency to develop a national formulary and a bulk purchasing strategy for cost-effective drug procurement. It also calls for a pan-Canadian strategy on appropriate prescription drug use. Additionally, the Minister of Health is tasked with forming a committee of experts to make recommendations on the operation and financing of a single-payer pharmacare model. By reducing financial barriers to essential medications, the Act addresses the healthcare needs of older persons, who often face higher medication costs due to age-related health conditions.